LONDON (AP) — Johnson & Johnson released information showing that a booster dose to its a person-shot coronavirus vaccine delivers a potent immune response months just after folks obtain a very first dose.
J&J reported in statement Tuesday that it ran two early scientific tests in persons previously specified its vaccine and located that a 2nd dose produced an greater antibody reaction in grown ups from age 18 to 55. The study’s outcomes have not nevertheless been peer-reviewed.
“A booster dose of the Johnson & Johnson COVID-19 vaccine even further increases antibody responses amongst examine individuals who had previously gained our vaccine,” reported Dr. Mathai Mammen, world wide head of exploration and improvement at J&J.
The company is in talks with regulators like the U.S. Food stuff and Drug Administration, the European Medications Company and some others regarding utilizing booster doses of its vaccine.